RESEARCH STATS
POOL
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
Interactions with Platform & by Email
PARTICIPANTS
Unique # Participated
VALIDATIONS
Responses Validated*
DATA ROOM
EXECUTIVE
CITATIONS
COMPANY
DISCUSSIONS
BRAND/PRODUCT
INSIGHTS
TOTAL
DATA STACK
*Clients have full access to our data room
DATE
SEP 2023
COMPANIES
79
TABLES
192
PAGES
472
EDITION
18
PRICE
USD 5600
CODE
MCP-7635
*Engagement stats are ongoing and dynamic
OUR EXPERT PANELS
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
WHY PARTICIPATE?
Expertise to the Power of YOU!
- Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
- Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
- Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
- Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
- Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription
- The Economist
- MIT Technology Review
- Harvard Business Review
Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.
MARKETGLASS
BASIC
- $500/Month/User. Extra Users @ $100/Month/User
- Annual Prepaid Subscription
- Single-User
- 10,000 Data Room Credits/Month
- Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
- Use MarketGlassTM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
- My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
PREMIUM
- $1000/Month/User. Extra Users @ $100/Month/User
- Annual Prepaid Subscription
- One Research Project With One Complimentary Update/Year
- 10-User License
- 10-User Peer-to-Peer Collaborative Features
- 200 Domain Expert Insights (With Name, Company, and Date)
- 50,000 Data Room Credits
- Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
- Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
- Use Your Own Data and MarketGlassTM Data Room Content.
- My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
- Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges
ENTERPRISE
- $2500/Month/User. Extra Users @ $150/Month/User
- Annual Prepaid Subscription
- Four Research Projects With One Complimentary Update/Year
- 25-User License
- 25-User Peer-to-Peer Collaborative Engagements
- 500 Domain Expert Insights (With Name, Company, and Date)
- 150,000 Data Room Credits
- Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
- Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
- Use Your Own Data and MarketGlassTM Data Room Content.
- My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
- Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges
HIGHLIGHTS & REPORT INDEX
What`s New?
» Special discussions on the global economic climate and market sentiment
» Coverage on global competitiveness and key competitor percentage market shares
» Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass™ research platform
» Complimentary updates for one year
» Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes
Economic Outlook
The global economic outlook is improving, and growth recovery, albeit on the lower side, is expected for this year and the next. The United States although witnessing slowing GDP growth in response to tight monetary and financial conditions, has nevertheless overcome the recession threat. Easing of headline inflation in Euro area is helping boost real incomes and is contributing to pick-up in economic activity. China is expected to see strong increases in GDP in the coming year as the pandemic threat recedes and the government sheds its zero-COVID policy. With optimistic GDP projections, India remains on-course to emerge into a US$6 trillion economy by 2030, surpassing Japan and Germany.
The upturn, however, remains fragile and a number of interlocking challenges continue to run in parallel, such as continued uncertainty around the war in Ukraine; slower than expected decline in global headline inflation; continuation of food and fuel inflation as a persistent economic problem for most developing countries; and still high retail inflation and its impact on consumer confidence and spending. Countries and their governments are showing signs of weathering these challenges, which helps lift market sentiments. As governments continue to combat inflation to get it down to more economically conformable levels by raising interest rates, new job creation will slowdown and impact economic activity. Stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.
Although corporate investments can likely be held back by inflation worries and weaker demand, rise of new technologies will reverse partially this prevailing investment sentiment. Rise of generative AI; applied AI; industrializing machine learning; next-generation software development; Web3; cloud and edge computing; quantum technologies; electrification and renewables and climate technologies beyond electrification and renewables, will open up the global investment landscape. The technologies hold the potential to drive sizeable incremental growth and value to global GDP in the coming years. The short-term is expected to be a mixed bag of challenges and opportunities for both consumers and investors alike. There is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global ADME-Toxicology Testing Market to Reach $17.3 Billion by 2030
The global market for ADME-Toxicology Testing estimated at US$7.7 Billion in the year 2022, is projected to reach a revised size of US$17.3 Billion by 2030, growing at aCAGR of 10.6% over the period 2022-2030. Cell Culture, one of the segments analyzed in the report, is projected to record 12.6% CAGR and reach US$8.8 Billion by the end of the analysis period. Growth in the High Throughput Screening segment is estimated at 7.4% CAGR for the next 8-year period.
The U.S. Market is Estimated at $3.8 Billion, While China is Forecast to Grow at 14% CAGR
The ADME-Toxicology Testing market in the U.S. is estimated at US$3.8 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 14% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.4% and 11.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.1% CAGR.
SELECT PLAYERS
Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; Corning, Inc.; BD Biosciences; Charles River Laboratories International, Inc.; AB Sciex LLC; Dassault Systemes SE (3DS); Cyprotex Limited; BioReliance Corporation; Crown Bioscience, Inc.; Envigo, Inc.; ADMEcell, Inc.; Endonovo Therapeutics, Inc.; CN Bio Innovations Ltd.; Emulate, Inc.
SEGMENTS
» Technology (Cell Culture, High Throughput Screening, Molecular Imaging, OMICS, Other Technologies) » Method (Cellular Assay, Biochemical Assay, Ex-Vivo, In Silica) » Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications)
GEOGRAPHIES
» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Latin America » Middle East » Africa
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Influencer Market Insights |
World Market Trajectories |
ADME-Toxicology Testing – Global Key Competitors Percentage Market Share in 2022 (E) |
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
ADME-Tox : An Introduction |
A Prelude to ADME Toxicology Testing |
Impact of Covid-19 and a Looming Global Recession |
2020 Marked as a Year of Disruption & Transformation |
As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021 |
EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022 |
COVID-19 IMPACT ON ADME TOXICOLOGY TESTING MARKET |
Global Market Prospects and Growth Drivers |
Drug Makers Bet on ADME & Toxicology Testing to Improve Success Rate for Potential Drug Candidates |
Cell Culture Holds a Major Share of the Market |
North America and Europe Dominate, Asia-Pacific Witnesses Rapid Growth |
Competition |
Recent Market Activity |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
Increased Need to Check Late-Stage Drug Failures Drive Market Growth |
Exhibit: Steady Increase in Average Drug Development Cost and Efforts to Mitigate Late-Stage Drug Failure Rates Highlights the Role of ADME-Toxicology Testing: Average Cost of Drug Development (in US$ Billion) in the US since 1980s |
Impact of ADME-Tox Screening on New Drug Discovery |
TABLE 1: Phase-I Clinical Trial Failures Before and After the Advent of Preclinical ADME/Pharmacokinetics |
EXHIBIT: actors Leading to Failure of Drugs in Phase III Clinical Trials: Percentage Breakdown of Number of Cases for Efficacy, Pharmacokinetics, Toxicity and Others |
EXHIBIT: Drug Withdrawals Due to Toxicity Issues (1990-early 2010s): Percentage Share Breakdown of Number of Drugs Withdrawn Due to Cardiotoxicity, Hepatotoxicity and Others |
Pharma Industry Renews Focus on Cost Optimization |
EXHIBIT: Global Pharmaceutical R&D Spending (US$ Billion) for the Years 2011 through 2020 |
EXHIBIT: New FDA Approvals (2010-2020): Breakdown of Number of Approvals by Type for New Molecular Entity (NME) and Biologic License Application (BLA) Approvals |
China and India: Hot Spots for R&D Investment |
EXHIBIT: World R&D Market by Geographic Region (2020): Percentage Breakdown of R&D Spending for Asia, Europe, Middle East & Africa, North America and South America |
Growth Momentum Shifts Away from In Vivo Technologies; In Vitro Technologies to Lead the Charge |
Growing Prominence of Cell-based Assays in Drug Discovery and ADME Analysis |
EXHIBIT: Global Cell-based Assays Market by Segment (2020): Percentage Share Breakdown of Value Sales for Consumables, Instruments, Software, and Services |
EXHIBIT: Global Market for Cell-based Assays by End-User (2020): Percentage Share Breakdown of Value Sales for Pharma & Biotech Companies, Government & Academic Institutes, CROs, and Others |
EXHIBIT: World Cell-based Assays Market by Application (2020): Percentage Breakdown of Revenue for ADME, Basic Research and Drug Discovery |
Major Types of Cell-Based HTS Assays for Drug Screening |
Cell-based Assays in HTS and UHTS |
Innovation in Screening Guarantees Success for Drug Discovery Programs |
High-Content Screening (HCS) - An Expanding Technology in Cell-Based Assays |
High Content Screening - Key Application Areas |
HCS Market Ripe with Growth Opportunity |
HCS vs. HTS |
Increasing Use of Cell-Based Assays over Other Methods in Toxicity Testing |
3D Cell Culture Technology to Put a New Spin on In Vitro Cell Analyses |
CDER’s DARS 2—Microphysiological 3D Cell Culture Platforms as Drug Development Tools |
Rising Investment in Proteomics R&D Drive Cell-based Assays Market |
Automated Multiplexing Platforms Present Growth Opportunities |
Automation of Cell-based Assays: A Growing Trend |
In-Silico ADME Emerge as Compelling Drug Discovery & Development Tool |
Advantages of Using In Silico Approaches |
Personalized Treatments & Computational Tools: Intriguing Facets of ADME R&D ADME Pharmacogenomics to Power Personalized Treatments |
ADME Research & Emerging Computational Tools |
Omics Technology |
Adoption of Omics-based Technologies |
In Vitro 3D Organoid Models to Meet ADME-Toxicity Testing Needs |
Limitations of Traditional in vitro Cellular Models |
Organoids Technology—Advanced in vitro 3D Platforms for More Physiologically Relevant Modeling |
Stem Cells Exude Great Potential in Drug Toxicity Testing |
Global Market for Stem Cell-Assays |
Functional Assays: An Effective Way of Predicting Specific Toxic Effects |
GPCR Targets to Drive Growth in Functional Cell Assay Market |
Molecular Imaging and ADME |
Organ-on-a-Chip Technology Gains Momentum in ADME Toxicology Testing |
Technological Advancements in ADME Toxicology Testing |
4. GLOBAL MARKET PERSPECTIVE |
World Recent Past, Current & Future Analysis for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Cell Culture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for High Throughput Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for High Throughput Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for High Throughput Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Molecular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Molecular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Molecular Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for OMICS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for OMICS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for OMICS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Cellular Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Cellular Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Cellular Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Biochemical Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Biochemical Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Biochemical Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Ex-Vivo by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Ex-Vivo by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Ex-Vivo by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for In Silica by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for In Silica by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for In Silica by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Systemic Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Systemic Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Systemic Toxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Renal Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Renal Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Renal Toxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Hepatotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Hepatotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Hepatotoxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Neurotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Neurotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Neurotoxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030 |
World ADME-Toxicology Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030 |
World Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
World Historic Review for ADME-Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for ADME-Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030 |
III. MARKET ANALYSIS |
UNITED STATES |
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E) |
USA Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
USA Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
USA 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030 |
USA Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
USA Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
USA 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030 |
USA Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
USA Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
USA 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030 |
CANADA |
Canada Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Canada Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Canada 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030 |
Canada Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Canada Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Canada 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030 |
Canada Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Canada Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Canada 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030 |
JAPAN |
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E) |
Japan Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Japan Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Japan 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030 |
Japan Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Japan Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Japan 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030 |
Japan Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Japan Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Japan 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030 |
CHINA |
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E) |
China Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
China Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
China 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030 |
China Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
China Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
China 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030 |
China Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
China Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
China 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030 |
EUROPE |
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E) |
Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Europe Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030 |
Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Europe Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030 |
Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Europe Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030 |
Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR |
Europe Historic Review for ADME-Toxicology Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for ADME-Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030 |
FRANCE |
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E) |
France Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
France Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
France 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030 |
France Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
France Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
France 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030 |
France Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
France Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
France 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030 |
GERMANY |
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E) |
Germany Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Germany Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Germany 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030 |
Germany Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Germany Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Germany 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030 |
Germany Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Germany Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Germany 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030 |
ITALY |
Italy Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Italy Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Italy 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030 |
Italy Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Italy Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Italy 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030 |
Italy Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Italy Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Italy 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030 |
UNITED KINGDOM |
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E) |
UK Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
UK Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
UK 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030 |
UK Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
UK Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
UK 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030 |
UK Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
UK Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
UK 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030 |
SPAIN |
Spain Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Spain Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Spain 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030 |
Spain Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Spain Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Spain 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030 |
Spain Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Spain Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Spain 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030 |
RUSSIA |
Russia Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Russia Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Russia 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030 |
Russia Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Russia Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Russia 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030 |
Russia Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Russia Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Russia 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Rest of Europe Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Rest of Europe 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030 |
Rest of Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Rest of Europe Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Rest of Europe 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030 |
Rest of Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Rest of Europe Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Rest of Europe 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030 |
ASIA-PACIFIC |
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E) |
Asia-Pacific Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Asia-Pacific Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Asia-Pacific 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030 |
Asia-Pacific Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Asia-Pacific Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Asia-Pacific 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030 |
Asia-Pacific Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Asia-Pacific Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Asia-Pacific 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030 |
LATIN AMERICA |
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E) |
Latin America Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Latin America Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Latin America 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030 |
Latin America Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Latin America Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Latin America 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030 |
Latin America Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Latin America Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Latin America 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030 |
MIDDLE EAST |
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E) |
Middle East Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Middle East Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Middle East 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030 |
Middle East Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Middle East Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Middle East 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030 |
Middle East Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Middle East Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Middle East 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030 |
AFRICA |
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E) |
Africa Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Africa Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Africa 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030 |
Africa Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Africa Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Africa 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030 |
Africa Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR |
Africa Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR |
Africa 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030 |
IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com
DIFFERENTIATORS
Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .
What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).
WHAT SETS US APART
FULL STACK DATA ACCESS
- Primary Research Cluster Data
- Influencer Engagement Stats
- Evidence of Primary Research
- List of Companies Engaged
- Hundreds of Pages of Research
- Peer Collaborative Interactions
- Enterprise Data Exchanges
- MarketGlassTM Platform Insider
- Geographic Pricing Dynamics
- Competitive Shares by Country
- Brand Curation & Insights
- Domain Expert Pool
Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.
Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.
Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.
Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.
Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.
Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.
Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.